Inhibition of Epstein-Barr virus reactivation by the flavonoid apigenin

BACKGROUND: Lytic reactivation of EBV has been reported to play an important role in human diseases, including NPC carcinogenesis. Inhibition of EBV reactivation is considered to be of great benefit in the treatment of virus-associated diseases. For this purpose, we screened for inhibitory compounds...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Biomed Sci
Prif Awduron: Wu, Chung-Chun, Fang, Chih-Yeu, Cheng, Yu-Jhen, Hsu, Hui-Yu, Chou, Sheng-Ping, Huang, Sheng-Yen, Tsai, Ching-Hwa, Chen, Jen-Yang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2017
Pynciau:
Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217310/
https://ncbi.nlm.nih.gov/pubmed/28056971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-016-0313-9
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg